MYRZEN ODT 15 MG COM ORODISP CT BL AL AL X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1004315950021 -
GGREM
508026090214607 -
Código de barras
7891317045920
O que a fonte publica
- Detentor do registro
- EUROFARMA LABORATORIOS S.A.
- Princípios ativos
- MIRTAZAPINA
- Embalagem
- 15 MG COM ORODISP CT BL AL AL X 30
- Regime de dispensação
- Tarja Vermelha sob restrição
- Tipo de produto
- Similar
- Classe terapêutica
- N6A9 - ANTIDEPRESSIVOS TODOS OS OUTROS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "MYRZEN ODT 15 MG COM ORODISP CT BL AL AL X 30",
"holder": "EUROFARMA LABORATORIOS S.A.",
"stripe": "Tarja Vermelha sob restrição",
"barcodes": [
"7891317045920"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "508026090214607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "61.190.096/0001-92",
"priceRegime": "Regulado",
"productName": "MYRZEN ODT",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "15 MG COM ORODISP CT BL AL AL X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha sob restrição",
"factoryPrices": {
"icms-0": "81.03",
"icms-12": "92.08",
"icms-17": "97.63",
"icms-18": "98.82",
"icms-19": "100.04",
"icms-20": "101.29",
"icms-21": "102.57",
"icms-22": "103.88",
"icms-23": "105.23",
"icms-17.5": "98.22",
"icms-19.5": "100.66",
"icms-20.5": "101.92",
"icms-22.5": "104.55",
"icms-12-alc": "90.97",
"icms-17-alc": "96.45",
"icms-18-alc": "97.63",
"icms-19-alc": "98.84",
"icms-20-alc": "100.07",
"icms-21-alc": "101.34",
"icms-22-alc": "102.64",
"icms-23-alc": "103.97",
"withoutTaxes": "80.06",
"icms-17.5-alc": "97.04",
"icms-19.5-alc": "99.45",
"icms-20.5-alc": "100.70",
"icms-22.5-alc": "103.30"
},
"pisCofinsList": "Positiva",
"substanceText": "MIRTAZAPINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "111.69",
"icms-12": "126.92",
"icms-17": "134.57",
"icms-18": "136.21",
"icms-19": "137.89",
"icms-20": "139.62",
"icms-21": "141.38",
"icms-22": "143.19",
"icms-23": "145.05",
"icms-17.5": "135.39",
"icms-19.5": "138.75",
"icms-20.5": "140.49",
"icms-22.5": "144.11",
"icms-12-alc": "125.76",
"icms-17-alc": "133.34",
"icms-18-alc": "134.97",
"icms-19-alc": "136.64",
"icms-20-alc": "138.34",
"icms-21-alc": "140.10",
"icms-22-alc": "141.89",
"icms-23-alc": "143.73",
"withoutTaxes": "110.67",
"icms-17.5-alc": "134.15",
"icms-19.5-alc": "137.48",
"icms-20.5-alc": "139.21",
"icms-22.5-alc": "142.81"
},
"invalidBarcodes": [],
"activeSubstances": [
"MIRTAZAPINA"
],
"therapeuticClass": "N6A9 - ANTIDEPRESSIVOS TODOS OS OUTROS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1004315950021",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "N6A9",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:508026090214607"